Exact Mass: 442.1715476
Exact Mass Matches: 442.1715476
Found 240 metabolites which its exact mass value is equals to given mass value 442.1715476
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cortisol 21-sulfate
Cortisol 21-sulfate is also known as Cortisol-21-sulfuric acid or 4-Pregnen-11,17,21-triol-3,20-dione 21-sulfate. Cortisol 21-sulfate is considered to be practically insoluble (in water) and acidic. Cortisol 21-sulfate is a steroid conjugate lipid molecule D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Eltrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
beta-D-Xylopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->2)-D-fucose
beta-D-Xylopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->2)-D-fucose is a constituent of desacylsaponins from the bark of Quillaja saponaria (soapbark tree). Constituent of desacylsaponins from the bark of Quillaja saponaria (soap-bark tree)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine
C16H31N2O10P (442.17162360000003)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is an acylcarnitine. More specifically, it is an 3-[(2R)-2-hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Eltrombopag
B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Hydrocortisone phosphate
16,19-Secostrychnidine-10,16-dione, 21,22-epoxy-21,22-dihydro-4,14-dihydroxy-3-methoxy-19-methyl-, (21.alpha.,22.alpha.)-
(1S,3R,5S,6S,8S,9S,10R,13R)-1-acetoxy-3-bromo-6-hydroxy-8,13-epoxylabd-14-ene
C22H35BrO4 (442.17185700000005)
3beta,4alpha-dihydroxy-4-beta-(chloromethyl)-8alpha-(4-hydroxymethacrylate)-11beta,13-dihydro-13-isopropyl-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14)-en-6,12-olide|Diain
Dienestrol glucuronide|O1-[alpha,alpha-Di-((E)-aethyliden)-4-hydroxy-bibenzyl-4-yl]-beta-D-glucopyranuronsaeure|O1-[alpha,alpha-di-((E)-ethylidene)-4-hydroxy-bibenzyl-4-yl]-beta-D-glucopyranuronic acid
8-(4-Hydroxyphenylactyl),Me ester-6,8,15-Trihydroxy-2-oxo-1(10),3,11(13)-guaiatrien-12-oic acid|Methyl 2-oxo-6alpha,15-dihydroxy-8alpha-(p-hydroxyphenylacetoxy)-guaia-1(10),3,11-trien-5alphaH-12-oate
2-(3,4-Dimethoxyphenyl)-3,5-dimethoxy-7-(2-hydroxy-3-methyl-3-butenyloxy)-4H-1-benzopyran-4-one
BENZYL 2,3-DI-O-ACETYL-4,6-O-BENZYLIDEN-|A-D-GLUCOPYRANOSIDE
3,4,17-trihydroxy-6,7-didehydro-aspidofractinine-1,3-dicarboxylic acid dimethyl ester|ent-(2S)-3alpha,4xi,17-Trihydroxy-6,7-didehydro-aspidofractinin-1,3beta-dicarbonsaeure-dimethylester|ent-(2S)-3alpha,4xi,17-trihydroxy-6,7-didehydro-aspidofractinine-1,3beta-dicarboxylic acid dimethyl ester|Kopsaporin
O-alpha-L-rhamnopyranosyl-(1-2)-O-alpha-L-rhamnopyranosyl-(1-5)-L-arabinose
C24H26O8_Spiro[furo[4,3,2-ij]pyrano[4,3:4,5]cyclohepta[1,2-f][2]benzopyran-7(9H),2-oxirane]-1,5,9,13(2H,3aH,11H)-tetrone, 5a,6,6a,13a,13b,13c-hexahydro-2,5a,11,11,13a-pentamethyl
Ala Asp His Thr
Ala Asp Thr His
Ala Glu His Ser
Ala Glu Ser His
Ala His Asp Thr
Ala His Glu Ser
Ala His Ser Glu
Ala His Thr Asp
Ala Ser Glu His
Ala Ser His Glu
Ala Thr Asp His
Ala Thr His Asp
Cys His Pro Ser
C17H26N6O6S (442.16344560000005)
Cys His Ser Pro
C17H26N6O6S (442.16344560000005)
Cys Pro His Ser
C17H26N6O6S (442.16344560000005)
Cys Pro Ser His
C17H26N6O6S (442.16344560000005)
Cys Ser His Pro
C17H26N6O6S (442.16344560000005)
Cys Ser Pro His
C17H26N6O6S (442.16344560000005)
Asp Ala His Thr
Asp Ala Thr His
Asp Asp Pro Pro
C18H26N4O9 (442.16997060000006)
Asp His Ala Thr
Asp His Thr Ala
Asp Pro Asp Pro
C18H26N4O9 (442.16997060000006)
Asp Pro Pro Asp
C18H26N4O9 (442.16997060000006)
Asp Thr Ala His
Asp Thr His Ala
Glu Ala His Ser
Glu Ala Ser His
Glu Gly His Thr
Glu Gly Thr His
Glu His Ala Ser
Glu His Gly Thr
Glu His Ser Ala
Glu His Thr Gly
Glu Ser Ala His
Glu Ser His Ala
Glu Thr Gly His
Glu Thr His Gly
Gly Glu His Thr
Gly Glu Thr His
Gly His Glu Thr
Gly His Thr Glu
Gly Thr Glu His
Gly Thr His Glu
His Ala Asp Thr
His Ala Glu Ser
His Ala Ser Glu
His Ala Thr Asp
His Cys Pro Ser
C17H26N6O6S (442.16344560000005)
His Cys Ser Pro
C17H26N6O6S (442.16344560000005)
His Asp Ala Thr
His Asp Thr Ala
His Glu Ala Ser
His Glu Gly Thr
His Glu Ser Ala
His Glu Thr Gly
His Gly Glu Thr
His Gly Thr Glu
His Pro Cys Ser
C17H26N6O6S (442.16344560000005)
His Pro Ser Cys
C17H26N6O6S (442.16344560000005)
His Ser Ala Glu
His Ser Cys Pro
C17H26N6O6S (442.16344560000005)
His Ser Glu Ala
His Ser Pro Cys
C17H26N6O6S (442.16344560000005)
His Thr Ala Asp
His Thr Asp Ala
His Thr Glu Gly
His Thr Gly Glu
Pro Cys His Ser
C17H26N6O6S (442.16344560000005)
Pro Cys Ser His
C17H26N6O6S (442.16344560000005)
Pro Asp Asp Pro
C18H26N4O9 (442.16997060000006)
Pro Asp Pro Asp
C18H26N4O9 (442.16997060000006)
Pro His Cys Ser
C17H26N6O6S (442.16344560000005)
Pro His Ser Cys
C17H26N6O6S (442.16344560000005)
Pro Pro Asp Asp
C18H26N4O9 (442.16997060000006)
Pro Ser Cys His
C17H26N6O6S (442.16344560000005)
Pro Ser His Cys
C17H26N6O6S (442.16344560000005)
Ser Ala Glu His
Ser Ala His Glu
Ser Cys His Pro
C17H26N6O6S (442.16344560000005)
Ser Cys Pro His
C17H26N6O6S (442.16344560000005)
Ser Glu Ala His
Ser Glu His Ala
Ser His Ala Glu
Ser His Cys Pro
C17H26N6O6S (442.16344560000005)
Ser His Glu Ala
Ser His Pro Cys
C17H26N6O6S (442.16344560000005)
Ser Pro Cys His
C17H26N6O6S (442.16344560000005)
Ser Pro His Cys
C17H26N6O6S (442.16344560000005)
Ser Ser Ser Tyr
C18H26N4O9 (442.16997060000006)
Ser Ser Tyr Ser
C18H26N4O9 (442.16997060000006)
Ser Tyr Ser Ser
C18H26N4O9 (442.16997060000006)
Thr Ala Asp His
Thr Ala His Asp
Thr Asp Ala His
Thr Asp His Ala
Thr Glu Gly His
Thr Glu His Gly
Thr Gly Glu His
Thr Gly His Glu
Thr His Ala Asp
Thr His Asp Ala
Thr His Glu Gly
Thr His Gly Glu
Tyr Ser Ser Ser
C18H26N4O9 (442.16997060000006)
Hydrocortisone phosphate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
b-D-Xylopyranosyl-(1->4)-a-L-rhamnopyranosyl-(1->2)-D-fucose
ST 21:3;O5;S
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
acetyl 4-[6-(4-acetyloxycarbonylphenoxy)hexoxy]benzoate
1-Boc-4-[4-(3,4-dichlorophenoxy)piperidin-1-ylmethyl]piperidine
C22H32Cl2N2O3 (442.17898619999994)
(-)-1,1-bis((2s,4s)-2,4-diethylphosphotano)ferrocene
C24H36FeP2 (442.16415059999997)
(s)-1-[(1r)-2-(diphenylphosphino)ferrocenyl]ethyldi-tert-butylphosphine
C24H36FeP2 (442.16415059999997)
2-[4-[(4-ethoxyphenyl)methylamino]phenyl]-1-ethylbenz[cd]indolium chloride
C28H27ClN2O (442.18118020000003)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine
C16H31N2O10P (442.17162360000003)
N-(3,4-dimethylphenyl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methoxyanilino]acetamide
C22H26N4O4S (442.16746760000007)
8-[(1-tert-butyl-5-tetrazolyl)-thiomorpholin-4-ylmethyl]-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-7-one
C21H26N6O3S (442.17870060000007)
[2-[(11S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
[(3aS,4S,9bR)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-(2-pyrazinyl)methanone
C26H23FN4O2 (442.18049499999995)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
methyl (1R,9S,10R,11R,17S)-14-ethenyl-13-(2-hydroxyacetyl)oxy-12,21-dioxa-8,18-diazahexacyclo[9.9.1.01,9.02,7.09,17.010,15]henicosa-2,4,6-triene-10-carboxylate
11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl hydrogen sulfate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
cortisol 21-sulfate
A steroid sulfate obtained by the formal condensation of hydroxy group at position 21 of cortisol with sulfuric acid. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
2-({4,5-dihydroxy-6-methyl-2-[(3,4,5-trihydroxyoxolan-2-yl)methoxy]oxan-3-yl}oxy)-6-methyloxane-3,4,5-triol
4-{4-[4-(acetyloxy)-3-methoxyphenyl]-hexahydrofuro[3,4-c]furan-1-yl}-2-methoxyphenyl acetate
18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4,9,11(21),16,18-pentaen-12-yl acetate
23-hydroxy-17,18-dimethoxy-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15(20),16,18-triene-21,24-dione
(2s,3r,4r,5r,6s)-2-{[(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2s,3r,4r,5s)-3,4,5-trihydroxyoxolan-2-yl]methoxy}oxan-3-yl]oxy}-6-methyloxane-3,4,5-triol
2-[(5-heptyl-7-hydroxy-4-oxochromen-2-yl)methyl]-3,4,6-trihydroxybenzoic acid
2-[2-(4-{2-hydroxy-5-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenyl)ethyl]benzene-1,4-diol
3-{3-[3-(3-hydroxy-5-methylphenoxy)-5-methylphenoxy]-5-methylphenoxy}-5-methylphenol
5-[2-(3-hydroxyphenyl)ethyl]-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}benzene-1,2-diol
acetoxyl oxokadsurane
{"Ingredient_id": "HBIN014435","Ingredient_name": "acetoxyl oxokadsurane","Alias": "NA","Ingredient_formula": "C24H26O8","Ingredient_Smile": "CC1CC2=CC(=C(C(=O)C23COC4=C3C(=CC5=C4OCO5)C(C1C)OC(=O)C)OC)OC","Ingredient_weight": "442.5 g/mol","OB_score": "28.59565179","CAS_id": "NA","SymMap_id": "SMIT11596","TCMID_id": "NA","TCMSP_id": "MOL010567","TCM_ID_id": "NA","PubChem_id": "49770118","DrugBank_id": "NA"}
1-{3-[(6-acetyl-5,7-dihydroxy-2,2-dimethylchromen-8-yl)methyl]-2,6-dihydroxy-4-methoxy-5-methylphenyl}ethanone
{5-[3-(acetyloxy)prop-1-en-1-yl]-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl}methyl acetate
(2e)-3-[(2s,3r)-3-[(acetyloxy)methyl]-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-en-1-yl acetate
3-(acetyloxy)-6-(2h-1,3-benzodioxol-5-yl)-5-methoxy-7-methyl-4-oxo-1-(prop-2-en-1-yl)bicyclo[3.2.1]oct-2-en-8-yl acetate
16,23-dihydroxy-17-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15,17,19-triene-21,24-dione
13,15-dimethyl (1s,2r,6r,14s,15r,16r,18s,20s)-15,20-dihydroxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate
3-[2-(4-hydroxy-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenyl)ethyl]benzene-1,2-diol
(2s)-2,4,9-trihydroxy-5,6-dimethoxy-7-methyl-8-(3-methylbut-2-en-1-yl)-2-(2-oxopropyl)phenalene-1,3-dione
(1'r,2r,2's,12'r,14'r,17'r,19'r,21's)-2',6',6',14',19'-pentamethyl-7',16',18'-trioxaspiro[oxirane-2,11'-pentacyclo[12.6.1.0²,¹².0⁵,¹⁰.0¹⁷,²¹]henicosane]-4',9'-diene-3',8',15',20'-tetrone
2,2-dimethyl-3-[(2-methylbut-2-enoyl)oxy]-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl 2,3-dimethyloxirane-2-carboxylate
13,15-dimethyl 15,20-dihydroxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate
2,4,9-trihydroxy-5,6-dimethoxy-7-methyl-8-(3-methylbut-2-en-1-yl)-2-(2-oxopropyl)phenalene-1,3-dione
2-(4-hydroxy-3-methoxyphenyl)-3,5,8-trimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
methyl 4-hydroxy-2-{[4-hydroxy-3-(3-hydroxy-3-methylbutyl)phenyl]methyl}-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate
5-[2-(4-hydroxyphenyl)ethyl]-4,6-bis[(4-hydroxyphenyl)methyl]benzene-1,3-diol
(2s,3r)-3,4,8-trihydroxy-2-(2-hydroxypropan-2-yl)-7-methoxy-6-(3-methylbut-2-en-1-yl)-2h,3h-furo[3,2-b]xanthen-5-one
4-[(1s,3ar,4s,6ar)-4-[4-(acetyloxy)-3-methoxyphenyl]-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenyl acetate
2-[2-(4-hydroxy-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenyl)ethyl]benzene-1,4-diol
(3r,4as,6s,6as,8r,10s,10ar,10bs)-8-bromo-3-ethenyl-6-hydroxy-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-10-yl acetate
C22H35BrO4 (442.17185700000005)